Brief: Adocia and Lilly announce successful completion insulin pump study biochaperone Lispro

Adocia SA

16/12/2016 17:01

Dec 16 (Reuters) - Adocia SA  ADOC.PA : 
    * Adocia and Lilly  LLY.N  announce successful completion of 
an insulin pump study with biochaperone Lispro in people with 
type 1 diabetes  
    * Biochaperone Lispro U100 demonstrated a statistically 
significant increase in insulin exposure over first 30 minutes 
after a mealtime bolus compared to humalog 
    * Biochaperone Lispro U100 and humalog showed similar safety 
results and were well tolerated 
    * An accelerated absorption profile of biochaperone lispro 
U100 was observed across three insulin delivery devices tested 
 
Source text for Eikon:  ID:nBwB4T8pa  
Further company coverage:  ADOC.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))